Status:
UNKNOWN
Iron Therapy in Patients With End-Stage Renal Disease
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions:
End-stage Renal Disease
Anemia
Eligibility:
All Genders
20-99 years
Phase:
NA
Brief Summary
This study will compare the clinical outcome of patients with maintenance dialysis room after changing the iron treatment guidelines from original upper limit with ferritin\>500ng/ml, or TSAT\>20% to ...
Detailed Description
After two years of treatments, we will compare the incidence of clinical events, monthly blood, and biochemical examination data for the two years before and after the change.
Eligibility Criteria
Inclusion
- patients receiving maintenance dialysis
Exclusion
- less than 20 year-old, oncological patients undergoing chemotherapy, abnormal liver function, infection
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04491916
Start Date
April 1 2020
End Date
December 31 2022
Last Update
July 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan